{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:21:20Z","timestamp":1770816080975,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ejim.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T02:27:02Z","timestamp":1320460022000},"page":"227-230","source":"Crossref","is-referenced-by-count":5,"title":["Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding"],"prefix":"10.1016","volume":"23","author":[{"given":"M.","family":"Struijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.F.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.C.","family":"van Tuyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"van de Ree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.10.004_bb0125","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.10.004_bb0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1592\/phco.29.7.812","article-title":"Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease","volume":"29","author":"Spinler","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2011.10.004_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-152-1-201001050-00179","article-title":"Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial","volume":"152","author":"Sung","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0020","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2011.10.004_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1076029608319945","article-title":"Prothrombotic and hemorrhagic effects of aspirin","volume":"15","author":"Aguejouf","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejim.2011.10.004_bb0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cgh.2006.04.019","article-title":"Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications","volume":"4","author":"Lai","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.10.004_bb0040","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrcardio.2010.185","article-title":"Antiplatelet therapy: clopidogrel\u2013PPI interaction, an ongoing controversy","volume":"8","author":"Gurbel","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2011.10.004_bb0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","article-title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel","volume":"180","author":"Juurlink","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.ejim.2011.10.004_bb0055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2011.10.004_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-152-6-201003160-00003","article-title":"Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study","volume":"152","author":"Ray","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0065","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/CIRCULATIONAHA.109.873497","article-title":"Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome","volume":"120","author":"Rassen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2011.10.004_bb0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-153-6-201009210-00005","article-title":"Proton-pump inhibitors are associated with increased cardiovascular risk independent of cloidogrel use: a nationwide cohort study","volume":"153","author":"Charlot","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0075","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0130","first-page":"1","article-title":"A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel","volume":"00","author":"Chen","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ejim.2011.10.004_bb0135","first-page":"CD001820","article-title":"Dipyridamole for preventing stroke and other vascular events in patients with vascular disease","author":"De Schryver","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2011.10.004_bb0090","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.amjmed.2003.10.040","article-title":"Effect of Helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs","volume":"116","author":"Papatheodoridis","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2036.2009.04133.x","article-title":"Predictors of gastroduodenal erosions in patients taking low-dose aspirin","volume":"31","author":"Hart","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.10.004_bb0105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2010.04415.x","article-title":"Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin","volume":"32","author":"Fletcher","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.10.004_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.10.004_bb0115","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.10.004_bb0120","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.3748\/wjg.v11.i25.3811","article-title":"Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users","volume":"11","author":"Papatheodoridis","year":"2005","journal-title":"World J Gastroenterol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T16:24:05Z","timestamp":1543422245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0953620511002366"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.10.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}